Related Experiment Video
Updated: Apr 24, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Temporal and spatial progression of microstructural cerebral degeneration in ALS: A multicentre longitudinal
Hans-Peter Müller1, Agessandro Abrahao2, Christian Beaulieu3
1Department of Neurology, University of Ulm, Ulm, Germany.
Diffusion tensor imaging (DTI) reveals progressive white matter changes in the corticospinal tract (CST) in amyotrophic lateral sclerosis (ALS). Fractional anisotropy (FA) along the CST serves as a reliable longitudinal biomarker for tracking ALS progression.
Area of Science:
- Neuroimaging
- Neurology
- Biomarker Discovery
Background:
- Amyotrophic lateral sclerosis (ALS) is characterized by progressive neurodegeneration.
- The corticospinal tract (CST) is significantly affected in ALS.
- Diffusion tensor imaging (DTI) can detect microstructural alterations in white matter.
Purpose of the Study:
- To evaluate fractional anisotropy (FA) along the CST as a longitudinal marker of disease progression in ALS.
- To assess microstructural changes in the CST using DTI in ALS patients.
- To establish DTI as a biomarker for cerebral degeneration in ALS.
Main Methods:
- A longitudinal, multicentre study (CALSNIC-2) involving 114 ALS patients and 110 healthy controls.
- Collection of DTI and clinical data using a harmonized protocol across 7 centers.
- Analysis using whole brain-based spatial statistics and tract-of-interest approaches for cross-sectional and longitudinal assessments.
Main Results:
- Reduced FA was observed longitudinally in the CST and mid-corpus callosum (CC) in ALS patients.
- CST and pontine FA correlated with functional impairment (ALSFRS-R) and disease progression rate.
- Longitudinal decline in FA was most pronounced in the lower CST, while cross-sectional changes were maximal in the upper CST.
Conclusions:
- Progressive microstructural alterations in ALS are most prominent in the CST and CC.
- DTI provides a feasible biomarker for cerebral degeneration in ALS.
- Longitudinal white matter changes in ALS are demonstrable within a practical observation period and participant number.
Related Concept Videos
Cross-bridge Cycle
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology
Dementia l: Introduction
Secondary Spinal Cord Injury llI: Pathophysiology

